Ocugen, Inc. OCGN
0.75 USD +0.02 (+2.83%)
At closeNov 3, 2026, 7:40 PM EST
0.78 +0.03 +4.67%
After hours · Nov 3, 7:40 PM ET
0.7317 Day range 0.7899
0.691 52-week range 2.73
- YTD
- -44.80%
- 1 year
- -51.61%
Analyst view
Price target (mean) 6.25 +738.7% upside
Now 0.7452
- Target (low)
- 4.00
- Target (mean)
- 6.25
- Target (high)
- 8.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.05667 | -0.06 – -0.05 | -0.03 | -88.9% | 300.00K | -78.9% | 3 |
| Next quarter | -0.06 | -0.07 – -0.05 | -0.05 | -20.0% | 0 | -100.0% | 2 |
| Current year | -0.19 | -0.20 – -0.18 | -0.26 | +26.9% | 3.62M | -40.0% | 3 |
| Next year | -0.26667 | -0.32 – -0.20 | -0.19 | -40.4% | 0 | -100.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 18, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 8, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Oct 23, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 15, 2024 | Maxim Group | Initiated | — | Buy |
| May 15, 2024 | Chardan Capital | Maintained | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 22, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Apr 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 24, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 31, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Aug 23, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 8, 2023 | Chardan Capital | Maintained | — | Buy |
| Apr 17, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 14, 2023 | Chardan Capital | Maintained | — | Buy |
| Mar 1, 2023 | Chardan Capital | Upgrade | Neutral | Buy |
| Mar 1, 2023 | Mizuho | Maintained | — | Buy |
| Mar 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Aug 23, 2022 | Mizuho | Initiated | — | Buy |
| Aug 15, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 2, 2022 | Cantor Fitzgerald | Initiated | — | Overweight |
| May 12, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 28, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 11, 2021 | Roth Capital | Downgrade | Buy | Neutral |
| Jun 11, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| May 7, 2021 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Mar 3, 2021 | Cantor Fitzgerald | Maintained | — | Overweight |
| Feb 9, 2021 | Chardan Capital | Downgrade | Buy | Neutral |